Results 91 to 100 of about 359,969 (268)

Mapping the lineage of prostate tissue ablation medical device predicates for focal therapy of prostate cancer approved via the FDA 510(k) clearance pathway

Surgical Practice, EarlyView.
Abstract Objective Medical devices are reviewed by the US Food and Drug Administration (FDA) for safety and effectiveness. Class II devices can receive 510(k) clearance if they are “substantially equivalent” to an existing predicate device. This process can be repeated iteratively, leading to a lineage of predicates for newly cleared devices.
Yiting Lin, Amir Khan, Arvin George, Mohummad Minhaj Siddiqui   +3 more
wiley   +1 more source

Algorithm for a short course of finasteride in patients with benign prostatic hyperplasia before transurethral resection of the prostate

Медицинский совет, 2014
Benign prostatic hyperplasia (BPH), for a long time known as benign prostatic hypertrophy, is so widespread that many researchers say, it inevitably occurs in men who have lived long enough for BPH to develop.
KB Kolontarev, GR Kasyan
doaj   +1 more source

The Benign Prostatic Hyperplasia and Its Aetiologies [PDF]

, 2018
This study aimed at investigating the Benign Prostatic Hyperplasia and Its Aetiologies, therefore th prostatic hyperplasia predominantly involves the stromal compartment of the gland and affects more than 70% of men of 70 years or older with or without ...
ALHARBI, MOAZ HASSAN H, ALHARTHI, MOHAMMED ABDULLAH M, NAWAF S, ALOTAIBI SAUD, ALSHAMMARI, MASOUD BASHEER O, ALENZI, AHMAD ENAD J, ALMISTAREHI, ABDEL HAMEED WASFI M, ALHAZMI, ALMOTASEM BLLAH ALI Y   +6 more
core  

Transition Zone Prostate Cancer: Quantitative Synthetic MR Imaging and Diffusion‐Weighted Imaging in Tumour Detection

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Background Differentiating transition zone (TZ) prostate cancer (PCa) from benign prostatic hyperplasia (BPH) on multiparametric MRI is challenging. The comparative performance of synthetic MRI (Sy‐MRI) and apparent diffusion coefficient (ADC) for this task is unclear.
Yu Zhang, Feng Li, Lei Song, Yanlong Jia, Zhihao Li, Shijun Jia   +5 more
wiley   +1 more source

Magnitude and factors associated with benign prostatic hyperplasia among adult male patients visiting Wolaita Sodo University comprehensive specialized hospital southern Ethiopia

Scientific Reports
Worldwide, in Africa and Ethiopia prevalence of Benign Prostatic Hyperplasia among patients with lower urinary tract symptoms was 26.2%, 44.2%, and 33.4% respectively.
Tirufat Tiruneh, Tamiru Getachew, Firdawek Getahun, Tesfaye Gebreyesus, Simeon Meskele   +4 more
doaj   +1 more source

Role of prostatic artery embolization in management of symptomatic benign prostatic hyperplasia

The Egyptian Journal of Radiology and Nuclear Medicine, 2016
Objectives: To assess the feasibility and efficacy of prostatic artery embolization in relieving symptoms of benign prostatic hyperplasia. Materials and methods: In a prospective study 28 patients with symptomatic benign prostatic hyperplasia were ...
Mohamed Shaker, Karim A. Abd El Tawab, Khaled H. Abd El Tawab, Mohamed El-Gharib   +3 more
doaj   +1 more source

Interventional Radiology Society of Australasia Quality Care Guidelines for Prostate Artery Embolisation for Men With Symptomatic Benign Prostatic Hyperplasia in Australia and New Zealand

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Objective This guideline defines recommendations for the provision of quality care for prostate artery embolisation (PAE) treatment for symptomatic benign prostatic hyperplasia (BPH). It has been developed using the AGREE‐II framework and aligns with current evidence, sourced from Randomised Controlled Trials, meta‐analyses and expert ...
William E. L. Ormiston, Glen Schlaphoff, Andrew Owen, Brendan Buckley, Dinesh Ranatunga, Christopher Rogan, Nicholas I. Brown   +6 more
wiley   +1 more source

Treatment of benign prostate hyperplasia [PDF]

Orvosi Hetilap, 2010
A koztudatban az urologiahoz kotődő leggyakoribb betegseg a vizeleturites zavara, amelyet kulonboző betegsegek okoznak, es amelynek osszefoglalo elnevezese a LUTS (lower urinary tract symptoms). A vizeleturitesi zavarok leggyakoribb oka a benignus prostatahyperplasia (BPH), bar a BPH-nak standardizalt klinikai defi nicioja nincs.
openaire   +2 more sources

Effect of combination treatment on patient-related outcome measures in benign prostatic hyperplasia: clinical utility of dutasteride and tamsulosin

Patient Related Outcome Measures, 2011
Bob Djavan, Seyed Saeid Dianat, Amir KazzaziNew York University, Department of Urology, New York, USABackground: Benign prostatic hyperplasia, the fourth most commonly diagnosed medical condition in the elderly, is a major underlying cause of lower ...
Djavan B, Dianat SS, Kazzazi A
doaj  

Pterostilbene Effect on Inflammatory and Oxidation Markers in Benign Prostatic Hyperplasia Rats Model

Iraqi Journal of Pharmaceutical Sciences
Pterostilbene is a potent anti-inflammatory and antioxidant used to treat benign prostatic hyperplasia, which is brought on by the induction of testosterone propionate.
Mohammed Ridha Jawad, Ghaith Ali Jasim
doaj   +1 more source